Want to see HK:1419 full AI Analyst Report?
Human Health Holdings Ltd. (1419) Ratios
Human Health Holdings Ltd. Ratios
HK:1419's free cash flow for Q4 2025 was $68.78M. For the 2025 fiscal year, HK:1419's free cash flow was decreased by $-5.61M and operating cash flow was $74.39M. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.03 | 2.88 | 2.84 | 2.28 | 2.43 |
| Quick Ratio | 2.94 | 2.76 | 2.69 | 2.20 | 2.37 |
| Cash Ratio | 2.52 | 2.16 | 2.27 | 1.84 | 0.90 |
| Solvency Ratio | 0.35 | 0.32 | 0.32 | 0.56 | 1.05 |
| Operating Cash Flow Ratio | 0.69 | 0.48 | 0.05 | 1.90 | 0.98 |
| Short-Term Operating Cash Flow Coverage | 3.97 | 5.78 | 0.36 | 18.19 | 7.01 |
| Net Current Asset Value | $ 356.93M | $ 297.43M | $ 323.91M | $ 341.72M | $ 315.26M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.12 | 0.13 | 0.14 | 0.14 | 0.16 |
| Debt-to-Equity Ratio | 0.17 | 0.17 | 0.19 | 0.23 | 0.25 |
| Debt-to-Capital Ratio | 0.14 | 0.15 | 0.16 | 0.18 | 0.20 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.34 | 1.37 | 1.38 | 1.56 | 1.56 |
| Debt Service Coverage Ratio | 2.44 | 4.10 | 2.56 | 5.93 | 9.82 |
| Interest Coverage Ratio | 16.34 | 15.13 | 2.18 | 37.01 | 146.15 |
| Debt to Market Cap | 0.13 | 0.05 | 0.08 | 0.05 | 0.07 |
| Interest Debt Per Share | 0.37 | 0.37 | 0.41 | 0.50 | 0.50 |
| Net Debt to EBITDA | -3.68 | -3.08 | -3.30 | -1.42 | -0.16 |
| Profitability Margins | |||||
| Gross Profit Margin | 46.35% | 46.02% | 45.67% | 59.22% | 58.81% |
| EBIT Margin | 5.85% | 4.87% | 6.07% | 24.80% | 39.95% |
| EBITDA Margin | 15.81% | 15.38% | 17.61% | 32.29% | 45.75% |
| Operating Profit Margin | 15.81% | 15.38% | 3.04% | 30.65% | 38.23% |
| Pretax Profit Margin | 4.64% | 4.65% | 4.50% | 23.84% | 39.69% |
| Net Profit Margin | 4.04% | 4.09% | 4.09% | 18.05% | 33.46% |
| Continuous Operations Profit Margin | 4.22% | 4.13% | 4.09% | 18.05% | 33.46% |
| Net Income Per EBT | 87.08% | 87.96% | 91.06% | 75.72% | 84.29% |
| EBT Per EBIT | 29.34% | 30.21% | 148.05% | 77.77% | 103.84% |
| Return on Assets (ROA) | 2.54% | 2.46% | 2.29% | 14.31% | 32.39% |
| Return on Equity (ROE) | 3.41% | 3.37% | 3.16% | 22.38% | 50.58% |
| Return on Capital Employed (ROCE) | 12.36% | 11.41% | 2.13% | 33.59% | 50.01% |
| Return on Invested Capital (ROIC) | 10.19% | 9.44% | 1.77% | 25.93% | 41.56% |
| Return on Tangible Assets | 2.75% | 2.66% | 2.37% | 14.73% | 33.47% |
| Earnings Yield | 9.79% | 8.36% | 6.07% | 25.08% | 60.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 13.53 | 10.32 | 13.52 | 9.86 | 2.66 |
| Payables Turnover | 6.29 | 4.89 | 6.22 | 7.12 | 11.45 |
| Inventory Turnover | 19.08 | 13.87 | 9.94 | 14.42 | 25.21 |
| Fixed Asset Turnover | 3.38 | 2.90 | 2.86 | 4.52 | 5.00 |
| Asset Turnover | 0.63 | 0.60 | 0.56 | 0.79 | 0.97 |
| Working Capital Turnover Ratio | 1.67 | 1.65 | 1.40 | 2.28 | 3.39 |
| Cash Conversion Cycle | -11.91 | -13.02 | 4.98 | 11.09 | 120.00 |
| Days of Sales Outstanding | 26.98 | 35.37 | 27.00 | 37.03 | 137.42 |
| Days of Inventory Outstanding | 19.13 | 26.31 | 36.71 | 25.31 | 14.48 |
| Days of Payables Outstanding | 58.02 | 74.70 | 58.73 | 51.25 | 31.89 |
| Operating Cycle | 46.11 | 61.68 | 63.71 | 62.34 | 151.89 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.38 | 0.26 | 0.03 | 1.75 | 0.78 |
| Free Cash Flow Per Share | 0.36 | 0.24 | -0.07 | 1.53 | 0.58 |
| Dividend Paid and CapEx Coverage Ratio | 6.98 | 5.29 | 0.11 | 3.36 | 2.42 |
| Capital Expenditure Coverage Ratio | 17.79 | 12.53 | 0.29 | 7.91 | 3.87 |
| Operating Cash Flow Coverage Ratio | 1.07 | 0.72 | 0.08 | 3.64 | 1.57 |
| Operating Cash Flow to Sales Ratio | 0.21 | 0.15 | 0.02 | 0.66 | 0.26 |
| Free Cash Flow Yield | 48.66% | 28.42% | -7.07% | 80.46% | 35.45% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 10.21 | 11.96 | 16.48 | 3.99 | 1.65 |
| Price-to-Sales (P/S) Ratio | 0.41 | 0.49 | 0.67 | 0.72 | 0.55 |
| Price-to-Book (P/B) Ratio | 0.35 | 0.40 | 0.52 | 0.89 | 0.83 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 2.06 | 3.52 | -14.15 | 1.24 | 2.82 |
| Price-to-Operating Cash Flow Ratio | 1.94 | 3.24 | 35.14 | 1.09 | 2.09 |
| Price-to-Earnings Growth (PEG) Ratio | 3.37 | 1.34 | -0.19 | -0.08 | 0.01 |
| Enterprise Value Multiple | -1.07 | 0.10 | 0.53 | 0.81 | 1.05 |
| Enterprise Value | -113.14M | 9.67M | 55.41M | 262.38M | 536.81M |
| EV to EBITDA | -1.07 | 0.10 | 0.53 | 0.81 | 1.05 |
| EV to Sales | -0.17 | 0.01 | 0.09 | 0.26 | 0.48 |
| EV to Free Cash Flow | -0.84 | 0.11 | -1.97 | 0.45 | 2.45 |
| EV to Operating Cash Flow | -0.79 | 0.10 | 4.89 | 0.39 | 1.81 |
| Tangible Book Value Per Share | 1.88 | 1.85 | 1.93 | 2.04 | 1.86 |
| Shareholders’ Equity Per Share | 2.09 | 2.06 | 2.02 | 2.13 | 1.95 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.09 | 0.11 | 0.09 | 0.24 | 0.16 |
| Revenue Per Share | 1.77 | 1.70 | 1.56 | 2.64 | 2.96 |
| Net Income Per Share | 0.07 | 0.07 | 0.06 | 0.48 | 0.99 |
| Tax Burden | 0.87 | 0.88 | 0.91 | 0.76 | 0.84 |
| Interest Burden | 0.79 | 0.95 | 0.74 | 0.96 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.31 | 0.31 | 0.31 | 0.21 | 0.15 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 5.27 | 3.69 | 0.47 | 3.67 | 0.79 |
Currency in HKD
